149 related articles for article (PubMed ID: 24568663)
1. Class switch recombination process in ataxia telangiectasia patients with elevated serum levels of IgM.
Mohammadinejad P; Abolhassani H; Aghamohammadi A; Pourhamdi S; Ghosh S; Sadeghi B; Nasiri Kalmarzi R; Durandy A; Borkhardt A
J Immunoassay Immunochem; 2015; 36(1):16-26. PubMed ID: 24568663
[TBL] [Abstract][Full Text] [Related]
2. Effect of Class Switch Recombination Defect on the Phenotype of Ataxia-Telangiectasia Patients.
Amirifar P; Mozdarani H; Yazdani R; Kiaei F; Moeini Shad T; Shahkarami S; Abolhassani H; Delavari S; Sohani M; Rezaei A; Hassanpour G; Akrami SM; Aghamohammadi A
Immunol Invest; 2021 Feb; 50(2-3):201-215. PubMed ID: 32116070
[No Abstract] [Full Text] [Related]
3. Class-Switch Recombination (CSR)/Hyper-IgM (HIGM) Syndromes and Phosphoinositide 3-Kinase (PI3K) Defects.
Jhamnani RD; Nunes-Santos CJ; Bergerson J; Rosenzweig SD
Front Immunol; 2018; 9():2172. PubMed ID: 30319630
[TBL] [Abstract][Full Text] [Related]
4. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination.
Imai K; Catalan N; Plebani A; Maródi L; Sanal O; Kumaki S; Nagendran V; Wood P; Glastre C; Sarrot-Reynauld F; Hermine O; Forveille M; Revy P; Fischer A; Durandy A
J Clin Invest; 2003 Jul; 112(1):136-42. PubMed ID: 12840068
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin class switch recombination is impaired in Atm-deficient mice.
Lumsden JM; McCarty T; Petiniot LK; Shen R; Barlow C; Wynn TA; Morse HC; Gearhart PJ; Wynshaw-Boris A; Max EE; Hodes RJ
J Exp Med; 2004 Nov; 200(9):1111-21. PubMed ID: 15504820
[TBL] [Abstract][Full Text] [Related]
6. The clinical significance of complete class switching defect in Ataxia telangiectasia patients.
Ghiasy S; Parvaneh L; Azizi G; Sadri G; Zaki Dizaji M; Abolhassani H; Aghamohammadi A
Expert Rev Clin Immunol; 2017 May; 13(5):499-505. PubMed ID: 28162005
[TBL] [Abstract][Full Text] [Related]
7. Ataxia-telangiectasia in a patient presenting with hyper-immunoglobulin M syndrome.
Aghamohammadi A; Imai K; Moazzami K; Abolhassani H; Tabatabaeiyan M; Parvaneh N; Nasiri Kalmarzi R; Nakagawa N; Oshima K; Ohara O; Nonoyama S; Rezaei N
J Investig Allergol Clin Immunol; 2010; 20(5):442-5. PubMed ID: 20945614
[TBL] [Abstract][Full Text] [Related]
8. Genetic Risk Variants for Class Switching Recombination Defects in Ataxia-Telangiectasia Patients.
Amirifar P; Mehrmohamadi M; Ranjouri MR; Akrami SM; Rezaei N; Saberi A; Yazdani R; Abolhassani H; Aghamohammadi A
J Clin Immunol; 2022 Jan; 42(1):72-84. PubMed ID: 34628594
[TBL] [Abstract][Full Text] [Related]
9. Do elevated serum IgM levels have to be included in probable diagnosis criteria of patients with ataxia-telangiectasia?
Azarsiz E; Karaca NE; Gunaydin NC; Gulez N; Ozturk C; Aksu G; Genel F; Kutukculer N
Int J Immunopathol Pharmacol; 2014; 27(3):421-7. PubMed ID: 25280033
[TBL] [Abstract][Full Text] [Related]
10. A primary immunodeficiency characterized by defective immunoglobulin class switch recombination and impaired DNA repair.
Péron S; Pan-Hammarström Q; Imai K; Du L; Taubenheim N; Sanal O; Marodi L; Bergelin-Besançon A; Benkerrou M; de Villartay JP; Fischer A; Revy P; Durandy A
J Exp Med; 2007 May; 204(5):1207-16. PubMed ID: 17485519
[TBL] [Abstract][Full Text] [Related]
11. Ataxia-telangiectasia patients presenting with hyper-IgM syndrome.
Noordzij JG; Wulffraat NM; Haraldsson A; Meyts I; van't Veer LJ; Hogervorst FB; Warris A; Weemaes CM
Arch Dis Child; 2009 Jun; 94(6):448-9. PubMed ID: 19224889
[TBL] [Abstract][Full Text] [Related]
12. Inducible CO-stimulator molecule, a candidate gene for defective isotype switching, is normal in patients with hyper-IgM syndrome of unknown molecular diagnosis.
Lee WI; Zhu Q; Gambineri E; Jin Y; Welcher AA; Ochs HD
J Allergy Clin Immunol; 2003 Nov; 112(5):958-64. PubMed ID: 14610488
[TBL] [Abstract][Full Text] [Related]
13. ATM is required for efficient recombination between immunoglobulin switch regions.
Reina-San-Martin B; Chen HT; Nussenzweig A; Nussenzweig MC
J Exp Med; 2004 Nov; 200(9):1103-10. PubMed ID: 15520243
[TBL] [Abstract][Full Text] [Related]
14. Analysis of class switch recombination and somatic hypermutation in patients affected with autosomal dominant hyper-IgM syndrome type 2.
Imai K; Zhu Y; Revy P; Morio T; Mizutani S; Fischer A; Nonoyama S; Durandy A
Clin Immunol; 2005 Jun; 115(3):277-85. PubMed ID: 15893695
[TBL] [Abstract][Full Text] [Related]
15. Clinical Phenotypes of Hyper-IgM Syndromes.
de la Morena MT
J Allergy Clin Immunol Pract; 2016; 4(6):1023-1036. PubMed ID: 27836054
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and genetic analysis of Taiwanese patients with the hyper IgM syndrome phenotype.
Lee WI; Huang JL; Yeh KW; Yang MJ; Lai MC; Chen LC; Ou LS; Yao TC; Lin SJ; Jaing TH; Chen SH; Hsieh MY; Yu HH; Chien YH; Shyur SD
Pediatr Infect Dis J; 2013 Sep; 32(9):1010-6. PubMed ID: 23538518
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies.
Durandy A; Taubenheim N; Peron S; Fischer A
Adv Immunol; 2007; 94():275-306. PubMed ID: 17560278
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin class-switch recombination deficiencies.
Durandy A; Kracker S
Arthritis Res Ther; 2012 Jul; 14(4):218. PubMed ID: 22894609
[TBL] [Abstract][Full Text] [Related]
19. Causative mechanisms and clinical impact of immunoglobulin deficiencies in ataxia telangiectasia.
Takada S; Weitering TJ; van Os NJH; Du L; Pico-Knijnenburg I; Kuipers TB; Mei H; Salzer E; Willemsen MAAP; Weemaes CMR; Pan-Hammarstrom Q; van der Burg M
J Allergy Clin Immunol; 2024 May; 153(5):1392-1405. PubMed ID: 38280573
[TBL] [Abstract][Full Text] [Related]
20. A single-center study points to diverse features and outcome in patients with Hyperimmunoglobulin M Syndrome and Class- Switch Recombination defects.
Akarsu A; Halaçlı S; Tan Ç; Kuşkonmaz B; Küpesiz A; Çetinkaya D; Sanal Ö; Tezcan İ; Çağdaş D
Scand J Immunol; 2022 Nov; 96(5):e13213. PubMed ID: 36808635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
